Clinicopathologic features and long-term outcomes of Chinese patients with hepatocellular carcinoma in non-cirrhotic liver

Digestive Surgery

Volumn 25, Issue 5, 2008, Pages 376-382

  Xu, Li ^a   Huang, Liang ^a   Li, Bin Kui ^a   Zhang, Ya Qi ^a   Li, Jin Qing ^a   Yuan, Yun Fei ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Non cirrhotic liver

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BLEEDING; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHINESE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OVERALL SURVIVAL; PARTIAL HEPATECTOMY; PATIENT SAFETY; POSTOPERATIVE PERIOD; PROGNOSIS; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ALPHA-FETOPROTEINS; ANTINEOPLASTIC AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; BIOPSY; BLOOD LOSS, SURGICAL; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSTOPERATIVE CARE; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 55749095529     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000170881     Document Type: Article

References (18)

1. Wild CP, Hall AJ: Primary prevention of hepatocellular carcinoma in developing countries. Mutat Res 2000;462:381-393.
2. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, Wu ZQ, Fan J, Qin LX, Zheng BH: Experience of 1,000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 2001;91:1479-1486.
3. Lang H, Sotiropoulos GC, Brokalaki EI, Schmitz KJ, Bertona C, Meyer G, Frilling A, Paul A, Malago M, Broelsch CE: Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg 2007;205:27-36.
4. Laurent C, Blanc JF, Nobili S, Sa Cunha A, le Bail B, Bioulac-Sage P, Balabaud C, Capdepont M, Saric J: Prognostic factors and long-term survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 2005;201:656-662.
5. Brancatelli G, Federle MP, Grazioli L, Carr BI: Hepatocellular carcinoma in noncirrhotic liver: CT, clinical, and pathologic findings in 39 US residents. Radiology 2002;222:89-94.
6. Dupont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K: Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 2005;201:663-670.
7. Yuan YF, Li BK, Li JQ, Zhang YQ, Guo RP, Lin XJ, Li GH: Long-term prognosis after hepatic resection for huge primary liver cancer. Ai Zheng 2004;23:821-824.
8. Chang CH, Chau GY, Lui WY, Tsay SH, King KL, Wu CW: Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 2004;139:320-326.
9. Chen MF, Tsai HP, Jeng LB, Lee WC, Yeh CN, Yu MC, Hung CM: Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg 2003;27:443-447.
10. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, Kubota K, Zucchi A: No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 1999;134:984-992.
11. Bralet MP, Regimbeau JM, Pineau P, Dubois S, Loas G, Degos F, Valla D, Belghiti J, Degott C, Terris B: Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology 2000;32:200-204.
12. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J: Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol 2000;18:1094-1101.
13. Lubrano J, Huet E, Tsilividis B, Francois A, Goria O, Riachi G, Scotte M: Long-term outcome of liver resection for hepatocellular carcinoma in noncirrhotic nonfibrotic liver with no viral hepatitis or alcohol abuse. World J Surg 2008;32:104-109.
14. Verhoef C, de Man RA, Zondervan PE, Eijkemans MJ, Tilanus HW, Ijzermans JN: Good outcomes after resection of large hepatocellular carcinoma in the non-cirrhotic liver. Dig Surg 2004;21:380-386.
15. Yamashita Y, Taketomi A, Itoh S, Kitagawa D, Kayashima H, Harimoto N, Tsujita E, Kuroda Y, Maehara Y: Long-term favorable results of limited hepatic resections for patients with hepatocellular carcinoma: 20 years of experience. J Am Coll Surg 2007;205:19-26.
16. Nagasue N, Ono T, Yamanoi A, Kohno H, El-Assal ON, Taniura H, Uchida M: Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 2001;88:515-522.
17. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, Vetrone G, Cavallari A: Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther 2003;17(suppl 2):119-129.
18. Li JQ, Zhang YQ, Zhang WZ, Yuan YF, Li GH: Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy. J Cancer Res Clin Oncol 1995;121:364-366.